Harmony Biosciences Holdings, Inc. (HRMY) stock
HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.01+0.05 (+0.15%)
Close on Nov 17, 2026Market cap $1.92BP/E 10.7Yield –
Harmony Biosciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Harmony Biosciences's profit margin for the twelve months ending Jun 30, 2026 was 18.9%. For fiscal 2025 it was 18.3%, against 20.4% the year before. The highest annual figure on record is 41.4% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.3% | −2.1 |
| FY2024 | Dec 31, 2024 | 20.4% | −1.8 |
| FY2023 | Dec 31, 2023 | 22.1% | −19.3 |
| FY2022 | Dec 31, 2022 | 41.4% | +30.1 |
| FY2021 | Dec 31, 2021 | 11.3% | +34.5 |
| FY2020 | Dec 31, 2020 | -23.1% | +2511.9 |
| FY2019 | Dec 31, 2019 | -2535.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 28.9% | +9.0 |
| Q1 FY2026 | Mar 31, 2026 | 15.1% | −9.6 |
| Q4 FY2025 | Dec 31, 2025 | 9.2% | −15.4 |
| Q3 FY2025 | Sep 30, 2025 | 21.2% | −3.5 |
| Q2 FY2025 | Jun 30, 2025 | 19.8% | +13.1 |
| Q1 FY2025 | Mar 31, 2025 | 24.7% | −0.1 |
| Q4 FY2024 | Dec 31, 2024 | 24.6% | +8.8 |
| Q3 FY2024 | Sep 30, 2024 | 24.8% | +0.8 |
| Q2 FY2024 | Jun 30, 2024 | 6.7% | −18.8 |
| Q1 FY2024 | Mar 31, 2024 | 24.8% | +0.0 |
| Q4 FY2023 | Dec 31, 2023 | 15.8% | −22.0 |
| Q3 FY2023 | Sep 30, 2023 | 24.0% | −51.0 |
| Q2 FY2023 | Jun 30, 2023 | 25.6% | +3.6 |
| Q1 FY2023 | Mar 31, 2023 | 24.8% | −0.4 |
| Q4 FY2022 | Dec 31, 2022 | 37.8% | +12.9 |
| Q3 FY2022 | Sep 30, 2022 | 75.0% | +86.9 |
| Q2 FY2022 | Jun 30, 2022 | 22.0% | +2.9 |
| Q1 FY2022 | Mar 31, 2022 | 25.2% | +12.8 |
| Q4 FY2021 | Dec 31, 2021 | 24.9% | +25.3 |
| Q3 FY2021 | Sep 30, 2021 | -11.9% | −16.1 |
| Q2 FY2021 | Jun 30, 2021 | 19.1% | +19.2 |
| Q1 FY2021 | Mar 31, 2021 | 12.4% | +207.0 |
| Q4 FY2020 | Dec 31, 2020 | -0.4% | – |
| Q3 FY2020 | Sep 30, 2020 | 4.2% | – |
| Q2 FY2020 | Jun 30, 2020 | -0.1% | – |
| Q1 FY2020 | Mar 31, 2020 | -194.7% | – |
See a number that looks wrong?